748 A phase 1/2, open-label, dose-escalation, safety and tolerability study of NC762 in subjects with advanced or metastatic solid tumors

Han Myint; Satish Shah; Martin Gutierrez; Emese Zsiros; Megan Nelson; Stephanie Zeidan; Nadia Myrthil; Aaron Morawski; Alina Barbu; Jahangheer Shaik; Chelsea Zhou; Chrysi Kanellopoulou; Ron Copeland; Zachary Cusumano; Dallas Flies; Solomon Langermann; Patricia Lorusso; Kunle Odunsi

doi:10.1136/jitc-2022-SITC2022.0748

Article info

Regular and Young Investigator Award Abstracts

Clinical Trials In Progress

748 A phase 1/2, open-label, dose-escalation, safety and tolerability study of NC762 in subjects with advanced or metastatic solid tumors

Free

Authors

Han Myint NextCure Inc, Beltsville, MD, USA PubMed articles Google scholar articles
Satish Shah Pennsylvania Cancer Specialists, Gettysburg, PA, USA PubMed articles Google scholar articles
Martin Gutierrez John Theurer Cancer Center, Hackensack, NJ, USA PubMed articles Google scholar articles
Emese Zsiros Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA PubMed articles Google scholar articles
Megan Nelson NextCure, beltsville, MD, USA PubMed articles Google scholar articles
Stephanie Zeidan NextCure, beltsville, MD, USA PubMed articles Google scholar articles
Nadia Myrthil NextCure, beltsville, MD, USA PubMed articles Google scholar articles
Aaron Morawski NextCure, beltsville, MD, USA PubMed articles Google scholar articles
Alina Barbu NextCure, beltsville, MD, USA PubMed articles Google scholar articles
Jahangheer Shaik NextCure, beltsville, MD, USA PubMed articles Google scholar articles
Chelsea Zhou NextCure, beltsville, MD, USA PubMed articles Google scholar articles
Chrysi Kanellopoulou NextCure, beltsville, MD, USA PubMed articles Google scholar articles
Ron Copeland NextCure, beltsville, MD, USA PubMed articles Google scholar articles
Zachary Cusumano NextCure, beltsville, MD, USA PubMed articles Google scholar articles
Dallas Flies NextCure, beltsville, MD, USA PubMed articles Google scholar articles
Solomon Langermann NextCure, beltsville, MD, USA PubMed articles Google scholar articles
Patricia Lorusso Yale Cancer Center, New Haven, CT, USA PubMed articles Google scholar articles
Kunle Odunsi UFC Comprehensive Cancer Center, Chicago, IL, USA PubMed articles Google scholar articles

Citation

Myint H, Shah S, Gutierrez M, et al

748 A phase 1/2, open-label, dose-escalation, safety and tolerability study of NC762 in subjects with advanced or metastatic solid tumors

Journal for ImmunoTherapy of Cancer 2022;10:doi: 10.1136/jitc-2022-SITC2022.0748

Publication history

First published November 7, 2022.

Online issue publication

April 26, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password